Total Payments
$2,491
2024 Payments
$197.17
Companies
25
Transactions
139
Medicare Patients
6,092
Medicare Billing
$527,521
Payment Breakdown by Category
Food & Beverage$2,433 (97.7%)
Education$58.09 (2.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,433 | 137 | 97.7% |
| Education | $58.09 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $545.68 | 34 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $381.90 | 19 | $0 (2023) |
| Gilead Sciences, Inc. | $231.80 | 11 | $0 (2023) |
| Allergan Inc. | $209.96 | 16 | $0 (2019) |
| PFIZER INC. | $170.56 | 9 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $133.58 | 8 | $0 (2023) |
| Synergy Pharmaceuticals Inc | $110.71 | 5 | $0 (2018) |
| Janssen Biotech, Inc. | $87.31 | 6 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $76.57 | 4 | $0 (2021) |
| Celgene Corporation | $59.32 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $197.17 | 8 | PFIZER INC. ($76.00) |
| 2023 | $394.36 | 20 | ABBVIE INC. ($178.93) |
| 2022 | $273.31 | 14 | Gilead Sciences, Inc. ($79.23) |
| 2021 | $480.12 | 31 | AbbVie Inc. ($150.05) |
| 2020 | $196.13 | 11 | Intercept Pharmaceuticals, Inc. ($66.32) |
| 2019 | $210.32 | 19 | Allergan Inc. ($109.37) |
| 2018 | $348.43 | 19 | Intercept Pharmaceuticals, Inc. ($96.37) |
| 2017 | $391.44 | 17 | AbbVie, Inc. ($86.82) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: LIVER DISEASE | ||||||
| 10/24/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 10/01/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $31.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/09/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: Rare Disease | ||||||
| 08/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/13/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 04/18/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: Immunology | ||||||
| 12/04/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2023 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/09/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $9.09 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 09/19/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.06 | General |
| Category: Immunology | ||||||
| 09/06/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $26.37 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/06/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/19/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/11/2023 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $26.70 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Gastroenterology | ||||||
| 04/25/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.99 | General |
| Category: IMMUNOLOGY | ||||||
| 04/10/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Education | In-kind items and services | $22.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/05/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.07 | General |
| 03/23/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 1,521 | 1,702 | $747,915 | $130,986 |
| 2022 | 11 | 1,600 | 1,812 | $711,069 | $133,743 |
| 2021 | 14 | 1,573 | 1,856 | $727,757 | $147,133 |
| 2020 | 14 | 1,398 | 1,682 | $587,354 | $115,659 |
Total Patients
6,092
Total Services
7,052
Medicare Billing
$527,521
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 214 | 214 | $243,960 | $39,176 | 16.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 485 | 651 | $71,610 | $38,124 | 53.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 216 | 216 | $214,700 | $15,975 | 7.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 223 | 234 | $18,252 | $7,947 | 43.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 111 | 111 | $17,205 | $7,943 | 46.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 126 | 128 | $90,240 | $7,006 | 7.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 38 | 38 | $38,000 | $6,515 | 17.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 37 | 39 | $31,278 | $3,435 | 11.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 17 | 17 | $17,000 | $2,871 | 16.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 54 | 54 | $5,670 | $1,994 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 582 | 780 | $85,800 | $44,717 | 52.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 184 | 184 | $209,760 | $34,471 | 16.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 177 | 177 | $168,150 | $11,401 | 6.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 113 | 113 | $17,515 | $8,065 | 46.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 215 | 228 | $17,784 | $7,906 | 44.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 44 | 44 | $44,000 | $7,668 | 17.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 139 | 139 | $97,995 | $7,540 | 7.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 20 | 20 | $20,000 | $3,526 | 17.6% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 79 | 79 | $8,401 | $3,497 | 41.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 31 | 32 | $25,664 | $2,830 | 11.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 16 | 16 | $16,000 | $2,123 | 13.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 598 | 867 | $95,370 | $51,878 | 54.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 189 | 189 | $215,460 | $36,018 | 16.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 118 | 118 | $112,100 | $10,861 | 9.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 158 | 162 | $114,210 | $8,778 | 7.7% |
About Dr. Mrunal Patel, M.D
Dr. Mrunal Patel, M.D is a Gastroenterology healthcare provider based in Midland, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528000734.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mrunal Patel, M.D has received a total of $2,491 in payments from pharmaceutical and medical device companies, with $197.17 received in 2024. These payments were reported across 139 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,433).
As a Medicare-enrolled provider, Patel has provided services to 6,092 Medicare beneficiaries, totaling 7,052 services with total Medicare billing of $527,521. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Midland, TX
- Active Since 06/12/2006
- Last Updated 12/06/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1528000734
Products in Payments
- OCALIVA (Drug) $305.25
- LINZESS (Drug) $200.65
- XELJANZ (Drug) $124.42
- RINVOQ (Biological) $114.80
- Trulance (Drug) $110.71
- XIFAXAN (Drug) $107.92
- MAVYRET (Drug) $91.16
- HUMIRA (Biological) $78.92
- OCA (Drug) $76.65
- DUPIXENT (Biological) $69.99
- VIBERZI (Drug) $64.89
- ZEPOSIA (Drug) $59.32
- Viekira (Drug) $58.36
- STELARA (Biological) $55.15
- EVIS EXERA lll COLONOVIDEOSCOPE (Device) $55.04
- ORISE (Device) $54.79
- Amitiza (Drug) $54.33
- IBSRELA (Drug) $53.42
- Humira (Biological) $50.89
- SKYRIZI (Biological) $50.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Midland
Dr. Govind Patel, M.d, M.D
Gastroenterology — Payments: $74,476
Gastroenterology $74,476
Todd Holtz, Md, MD
Gastroenterology — Payments: $6,061
Gastroenterology $6,061
Karen Huang, D.o, D.O
Gastroenterology — Payments: $5,319
Gastroenterology $5,319
Christina Murphy, Do, DO
Gastroenterology — Payments: $4,372
Gastroenterology $4,372
Ernest Ofori-Darko, Md, MD
Gastroenterology — Payments: $4,351
Gastroenterology $4,351
Pratyusha Parava, M.d, M.D
Gastroenterology — Payments: $1,221
Gastroenterology $1,221